360 related articles for article (PubMed ID: 21036417)
21. Expression of Sézary Biomarkers in the Blood of Patients with Erythrodermic Mycosis Fungoides.
Hurabielle C; Michel L; Ram-Wolff C; Battistella M; Jean-Louis F; Beylot-Barry M; d'Incan M; Bensussan A; Bagot M
J Invest Dermatol; 2016 Jan; 136(1):317-20. PubMed ID: 26763453
[No Abstract] [Full Text] [Related]
22. Infectious events and associated risk factors in mycosis fungoides/Sézary syndrome: a retrospective cohort study.
Blaizot R; Ouattara E; Fauconneau A; Beylot-Barry M; Pham-Ledard A
Br J Dermatol; 2018 Dec; 179(6):1322-1328. PubMed ID: 30098016
[TBL] [Abstract][Full Text] [Related]
23. Basaloid folliculolymphoid hyperplasia: a distinctive finding in follicular mycosis fungoides.
Gerami P; Guitart J
J Cutan Pathol; 2007 Dec; 34 Suppl 1():29-32. PubMed ID: 17997735
[TBL] [Abstract][Full Text] [Related]
24. Juvenile mycosis fungoides: cutaneous T-cell lymphoma with frequent follicular involvement.
Hodak E; Amitay-Laish I; Feinmesser M; Davidovici B; David M; Zvulunov A; Pavlotsky F; Yaniv I; Avrahami G; Ben-Amitai D
J Am Acad Dermatol; 2014 Jun; 70(6):993-1001. PubMed ID: 24629999
[TBL] [Abstract][Full Text] [Related]
25. Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark.
Nielsen PR; Eriksen JO; Wehkamp U; Lindahl LM; Gniadecki R; Fogh H; Fabricius S; Bzorek M; Ødum N; Gjerdrum LM
Acta Derm Venereol; 2019 Dec; 99(13):1231-1236. PubMed ID: 31620804
[TBL] [Abstract][Full Text] [Related]
26. Purely follicular mycosis fungoides without mucinosis: report of two cases with review of the literature.
Monopoli A; Annessi G; Lombardo GA; Baliva G; Girolomoni G
J Am Acad Dermatol; 2003 Mar; 48(3):448-52. PubMed ID: 12637929
[TBL] [Abstract][Full Text] [Related]
27. Staging laparotomy in cutaneous T-cell disease.
Doyle JA; Winkelmann RK
Arch Dermatol; 1981 Sep; 117(9):543-6. PubMed ID: 6457567
[TBL] [Abstract][Full Text] [Related]
28. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
30. Alopecia mucinosa progressing into mycosis fungoides. A long-term follow-up study of two patients.
Sentis HJ; Willemze R; Scheffer E
Am J Dermatopathol; 1988 Dec; 10(6):478-86. PubMed ID: 2975474
[TBL] [Abstract][Full Text] [Related]
31. Epidermal Langerhans cells in mycosis fungoides and Sézary syndrome.
Matejka M; Konrad K
Wien Klin Wochenschr; 1983 Dec; 95(23):847-52. PubMed ID: 6670281
[TBL] [Abstract][Full Text] [Related]
32. Survival of mycosis fungoides in patients in the Southeast of England.
Morales MM; Putcha V; Evans HS; Olsen J; Llopis A; Møller H
Dermatology; 2005; 211(4):325-9. PubMed ID: 16286740
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics, risk factors and long-term outcome of 114 patients with folliculotropic mycosis fungoides.
Wieser I; Wang C; Alberti-Violetti S; Lyons G; Tran C; Talpur R; Duvic M
Arch Dermatol Res; 2017 Aug; 309(6):453-459. PubMed ID: 28516243
[TBL] [Abstract][Full Text] [Related]
34. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
Vinogradova IuE; Giliazitdinova EA; Zamulaeva IA; Zybunova EE; Kaplanskaia IB; Kravchenko SK; Kremenetskaia AM; Lutsenko IN; Samoĭlova RS; Selivanova EN; Sidorova IuV; Shklovskiĭ-Kord NE
Ter Arkh; 2005; 77(10):61-5. PubMed ID: 16320688
[TBL] [Abstract][Full Text] [Related]
35. Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides/Sézary syndrome.
Evans KG; Troxel AB; DeNardo BJ; Introcaso CE; Rook AH; Kim EJ
J Am Acad Dermatol; 2011 Apr; 64(4):682-9. PubMed ID: 21315479
[TBL] [Abstract][Full Text] [Related]
36. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
Edelson RL
J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
[TBL] [Abstract][Full Text] [Related]
38. Vitiligo vs. hypopigmented mycosis fungoides (histopathological and immunohistochemical study, univariate analysis).
El-Darouti MA; Marzouk SA; Azzam O; Fawzi MM; Abdel-Halim MR; Zayed AA; Leheta TM
Eur J Dermatol; 2006; 16(1):17-22. PubMed ID: 16436337
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome.
Klemke CD; Mansmann U; Poenitz N; Dippel E; Goerdt S
Br J Dermatol; 2005 Jul; 153(1):118-24. PubMed ID: 16029336
[TBL] [Abstract][Full Text] [Related]
40. What's new in the histologic evaluation of alopecia and hair-related disorders?
Elston DM
Dermatol Clin; 2012 Oct; 30(4):685-94, vii. PubMed ID: 23021054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]